Stock listing
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A
Selected listing: 603811 · SSE · CNY · CN
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A (Shanghai:603811), Health Technology. Latest release Sep 29, 2026: "Zhejiang Cheng Yi Pharmaceutical Co.…
- Ticker
- Shanghai:603811
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A, trading under the ticker 603811, operates in the pharmaceutical sector in China. It focuses on the development and production of pharmaceutical products to meet the needs of the healthcare market.
Latest news from Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on a Subsidiary's Receipt of Drug GMP Compliance Inspection Results
September 28, 2026
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing
September 17, 2026
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Satisfaction of Unlocking Conditions for the 1st Unlocking Period under the 2025 Employee Stock Ownership Plan
September 15, 2026
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 10, 2026
"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
August 26, 2026
Research Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A company profile
View the public company page for Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A on 6ix.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A news
Read company news and market updates connected to Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A investor events
Find investor webinars, events, and replay context for Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A.